POSITION STATEMENT ON METHADONE-MAINTENANCE TREATMENT

[1] [Anonymous], 2012, EFFECTIVENESS METHAD, DOI DOI 10.1007/978-1-4613-9089-3

[2] DESJARLAIS D, 1992, SUBSTANCE ABUSE COMP

[3] Dole, 1965, JAMA-J AM MED ASSOC, V193, P80

[4] A CONTROLLED TRIAL OF BUPRENORPHINE TREATMENT FOR OPIOID DEPENDENCE [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20): : 2750 - 2755

[5] BUPRENORPHINE DETOXIFICATION FROM OPIOID DEPENDENCE - A PILOT-STUDY [J]. LIFE SCIENCES, 1988, 42 (06) : 635 - 641

[6] KREEK MJ, 1983, RES TREATMENT NARCOT

[7] LING W, 1976, ARCH GEN PSYCHIAT, V33, P709

[8] McClellan A.T., 1993, JAMA-J AM MED ASSOC, V269, P1953

[9] METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049

[10] METHADONE TREATMENT - DEFINING AND EVALUATING SUCCESS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (07) : 447 - 450

[1] [Anonymous], 2012, EFFECTIVENESS METHAD, DOI DOI 10.1007/978-1-4613-9089-3

[2] DESJARLAIS D, 1992, SUBSTANCE ABUSE COMP

[3] Dole, 1965, JAMA-J AM MED ASSOC, V193, P80

[4] A CONTROLLED TRIAL OF BUPRENORPHINE TREATMENT FOR OPIOID DEPENDENCE [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20): : 2750 - 2755

[5] BUPRENORPHINE DETOXIFICATION FROM OPIOID DEPENDENCE - A PILOT-STUDY [J]. LIFE SCIENCES, 1988, 42 (06) : 635 - 641

[6] KREEK MJ, 1983, RES TREATMENT NARCOT

[7] LING W, 1976, ARCH GEN PSYCHIAT, V33, P709

[8] McClellan A.T., 1993, JAMA-J AM MED ASSOC, V269, P1953

[9] METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049

[10] METHADONE TREATMENT - DEFINING AND EVALUATING SUCCESS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (07) : 447 - 450